About ONCOtracker
ONCOtracker is a company based in West Hollywood (United States) founded in 2014 by James R Berenson.. ONCOtracker has raised $1.3 million across 3 funding rounds. ONCOtracker offers products and services including Serum BCMA Test, Immunoassays, Pre-clinical Drug Development, and Biospecimens. ONCOtracker operates in a competitive market with competitors including Guardant Health, Natera, Foundation Medicine, ArcherDX and Prenetics, among others.
- Headquarter West Hollywood, United States
- Founders James R Berenson
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Oncotracker, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1.3 M (USD)
in 3 rounds
-
Latest Funding Round
$150 K (USD), Seed
Feb 13, 2020
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ONCOtracker
ONCOtracker offers a comprehensive portfolio of products and services, including Serum BCMA Test, Immunoassays, Pre-clinical Drug Development, and Biospecimens. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Test for monitoring multiple myeloma biomarkers in patients.
Assays for pre-clinical drug development and research.
Support for oncology drug trials and evaluations.
Provision of samples for cancer research studies.
Funding Insights of ONCOtracker
ONCOtracker has successfully raised a total of $1.3M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $150 thousand completed in February 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Seed — $150,000
-
First Round
First Round
(10 Nov 2016)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2020 | Amount | Seed - ONCOtracker | Valuation |
investors |
|
| Mar, 2019 | Amount | Seed - ONCOtracker | Valuation |
investors |
|
| Nov, 2016 | Amount | Seed - ONCOtracker | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by ONCOtracker
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - ONCOtracker
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Oncotracker Comparisons
Competitors of ONCOtracker
ONCOtracker operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, Natera, Foundation Medicine, ArcherDX and Prenetics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Digital sequencing technology for cancer detection is developed.
|
|
| domain | founded_year | HQ Location |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| domain | founded_year | HQ Location |
Genomics-based diagnostic tests for cancer are provided.
|
|
| domain | founded_year | HQ Location |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| domain | founded_year | HQ Location |
Health risks are identified through online genetic and diagnostic testing.
|
|
| domain | founded_year | HQ Location |
Genomics-based diagnostic tests for cancer are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Oncotracker
Frequently Asked Questions about ONCOtracker
When was ONCOtracker founded?
ONCOtracker was founded in 2014 and raised its 1st funding round 2 years after it was founded.
Where is ONCOtracker located?
ONCOtracker is headquartered in West Hollywood, United States. It is registered at West Hollywood, California, United States.
Who is the current CEO of ONCOtracker?
James R Berenson is the current CEO of ONCOtracker. They have also founded this company.
Is ONCOtracker a funded company?
ONCOtracker is a funded company, having raised a total of $1.3M across 3 funding rounds to date. The company's 1st funding round was a Seed of $1.12M, raised on Nov 10, 2016.
What does ONCOtracker do?
Developer of immune assays for the diagnosis of cancer. The companys diagnostic assay is used for testing multiple myeloma, B-cell malignancies and other related disorders. It includes Serum B-Cell Maturation Antigen (sBCMA) blood test assay, which is used to monitor the tumour and predict the therapeutic outcome of patients with multiple myeloma. It is used to treat chronic lymphocytic leukaemia, B-cell lymphoma and solid tumour.
Who are the top competitors of ONCOtracker?
ONCOtracker's top competitors include Guardant Health, Exact Sciences and Foundation Medicine.
What products or services does ONCOtracker offer?
ONCOtracker offers Serum BCMA Test, Immunoassays, Pre-clinical Drug Development, and Biospecimens.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.